This concerns specifically the neurometabolic disorders, such as obesity and type 2 diabetes, that are characterised by widespread systemic alterations through diverse factors including, behavioural, neural, hormonal, adipose and intestinal along with the involvement of different mediators such as monoamine neurotransmitters, insulin and adipocytokines. This evidence concerns the gene INS and Obesity.